Results 101 to 110 of about 4,608 (197)

Type A botulinum neurotoxin complex proteins differentially modulate host response of neuronal cells

, 2014
Type A Botulinum neurotoxin (BoNT/A), the most potent poison known to mankind, is produced by Clostridium botulinum type A as a complex with neurotoxin-associated proteins (NAPs).
Yang, Weiping, Paul Lindo, Lei Wang, Weiping Yang, Bal Ram Singh, Wang, Lei, Yi Sun, Lindo, Paul, Sun, Yi, Singh, Bal Ram   +9 more
core   +1 more source

Critical analysis of the use of onabotulinumtoxinA (botulinum toxin type A) in migraine

Neuropsychiatric Disease and Treatment, 2012
Carrie E Robertson, Ivan GarzaDepartment of Neurology, Mayo Clinic, Rochester, MN, USAAbstract: OnabotulinumtoxinA, a neurotoxin, has been studied in numerous trials as a novel preventive therapy for migraine headache.
Robertson CE, Garza I
doaj  

Excitation-contraction coupling inhibitors potentiate the actions of botulinum neurotoxin type A at the neuromuscular junction [PDF]

Background and purpose: Botulinum neurotoxin type A1 (BoNT/A) is one of the most potent neurotoxins known. At the same time, it is also one of the safest therapeutic agents used for the treatment of several human disorders and in aesthetic medicine ...
Machicoane, Mickaël, Rossetto, Ornella, Pirazzini, Marco, Stazi, Marco, Megighian, Aram, Tonellato, Marika, Onillon, Paul, Corso, Mattia Dal, Le Doussal, Jean-Marc, Zainotto, Marica   +9 more
core   +1 more source

An Open Study of Botulinum-A Toxin Treatment of Idiopathic Trigeminal Neuralgia [PDF]

Patient Safety and Quality Improvement Journal, 2015
Introduction: Trigeminal Neuralgia (TN) is a unilateral, recurrent, sharp facial pain disorder that is limited to the distribution of divisions of the trigeminal nerve.
Karim Nikkhah, Mohammad Taghi Farzadfard, Payam Sasannejad, Ali Ghabeli Juibary, Marzieh Taheri, Samira Aminzadeh   +5 more
doaj  

Botulinum Neurotoxin Type A for the Treatment of Benign Prostatic Hyperplasia: Randomized Study Comparing Two Doses

, 2012
Purpose. To assess the efficacy and safety of intraprostatic injection of two botulinum neurotoxin type A (BoNT-A) doses for the treatment of benign prostatic hyperplasia (BPH). Materials and Methods. Men with symptomatic BPH who failed medical treatment
José de Bessa Junior, Malave, Cesar Augusto, Gomes, Cristiano Mendes, Bessa Junior, Jose de, Arnouk, Rene, Carlos Henrique Suzuki Bellucci, René Arnouk, Bellucci, Carlos Henrique Suzuki, Roberto Benatuil Stull, Stull, Roberto Benatuil, Cesar Augusto Malave, Cristiano Mendes Gomes   +11 more
core   +1 more source

Mandibular bone loss: a hidden side effect of botulinum toxin type A injection in masticatory muscles.

, 2020
Botulinum toxin type A (BoNTA) is the most potent serotype of a group ofneurotoxins produced by obligate anaerobic bacteria Clostridium botulinum. This neurotoxin blocks the release of acetylcholine from the motor neuron, uncoupling the neuromuscular ...
Buvinic, Sonja
core  

Botulinum toxin type A for upper limb spasticity after stroke

Spasticity is involuntary overactivity of muscles that occurs following upper motor neuron damage to the brain or spinal cord. Upper limb spasticity is common after stroke and can cause deformity, pain and reduced function.
Rodgers H, Shaw L
core  

Treatment of Vocal Fold Granuloma Using Botulinum Toxin Type A Injection

, 2000
The etiology of vocal fold granuloma was identified : post-endotracheal intubation, vocal abuse, acid reflux and idiopathic. The identification of the cause or causal factor is important, since the treatment must be fundamental directed at them ...
최홍식
core  

In Vivo Model of Short-Term Efficacy and Favorable Safety of Botulinum Toxin Type E Compared with Type A. [PDF]

Toxins (Basel)
Nam JS, Yoon D, Kim Y, Kim SY, Kim JY, Cha Y, Seok J, Kim BJ.   +7 more
europepmc   +1 more source